文献速递脑血管病

急性缺血性卒中伴未破裂颅内动脉瘤患者溶栓后动脉瘤破裂风险

Risk of Aneurysm Rupture After Thrombolysis in Patients With Acute Ischemic Stroke and Unruptured Intracranial Aneurysms.
PubMed 文献 · Neurology · 2021-10-06

141个囊状动脉瘤溶栓后均未破裂,但3例大型梭形基底动脉瘤患者发生致死性破裂,且均在溶栓后接受抗凝治疗。

要点

  • 囊状未破裂动脉瘤患者静脉溶栓后未见破裂,包括直径≥10mm者。
  • 大型梭形后循环动脉瘤患者溶栓后抗凝可能增加破裂风险。
  • 伴未破裂动脉瘤的急性缺血性卒中患者溶栓后总体症状性颅内出血率为8.3%。

核心结论

  • 静脉溶栓对伴囊状未破裂颅内动脉瘤的急性缺血性卒中患者似乎是安全的,包括大型(≥10mm)囊状动脉瘤。
  • 大型梭形后循环未破裂动脉瘤患者卒中后抗凝可能增加动脉瘤破裂风险。

研究设计与样本

  • 前瞻性队列研究,纳入2005至2019年某综合卒中中心连续接受静脉溶栓的急性缺血性卒中患者。

主要发现

  • 未破裂颅内动脉瘤平均直径4.7±3.8 mm,18.7%直径≥7 mm,9.7%≥10 mm。
  • 141个囊状未破裂动脉瘤溶栓后无一破裂。
  • 3例(2.3%,95%CI 0.6%-5.8%)大型梭形基底动脉未破裂动脉瘤患者分别在溶栓后27小时、43小时和19天发生致死性破裂。
  • 3例破裂患者均在溶栓后接受抗凝治疗,且破裂时抗凝治疗正在起效。
  • 所有患者中任何颅内出血发生率为18.9%(95%CI 12.9%-26.2%),症状性颅内出血发生率为8.3%(95%CI 4.4%-13.8%)。

关键数值与推荐

  • 症状性颅内出血采用ECASS-2标准,即NIHSS评分增加≥4分。
  • 主要结局为溶栓后归因于未破裂动脉瘤破裂的院内颅内出血。

临床怎么用

  • 对伴囊状未破裂颅内动脉瘤的急性缺血性卒中患者,静脉溶栓不应因动脉瘤存在而常规禁忌。
  • 对伴大型梭形后循环未破裂动脉瘤的患者,溶栓后抗凝需谨慎权衡动脉瘤破裂风险。

局限性

  • 研究为单中心前瞻性队列,样本中未破裂动脉瘤患者数量有限。
  • 梭形动脉瘤破裂事件仅3例,相关风险估计的置信区间较宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Unruptured intracranial aneurysms (UIAs) are considered to be a relative contraindication for IV thrombolysis (IVT) in acute ischemic stroke (AIS). Currently, however, data are limited on the risk of UIA rupture after IVT. Our objective was to assess whether IVT for AIS can lead to a UIA rupture and intracranial hemorrhages (ICHs) in patients with unruptured UIAs. METHODS: This was a prospective cohort study of consecutive patients treated in a comprehensive stroke center between 2005 and 2019. We assessed radiology reports and records at the Finnish Care Register for Health Care to identify patients with UIAs among all patients with AIS treated with IVT at the center. We analyzed patient angiograms for aneurysm characteristics and other brain imaging studies for ICHs after IVT. The main outcome was in-hospital ICHs attributable to a UIA rupture after IVT. Secondary outcomes were in-hospital symptomatic ICHs (European-Australian Cooperative Acute Stroke Study [ECASS-2] criteria, i.e., NIH Stroke Scale score increase ≥4 points) and any in-hospital ICHs. RESULTS: A total of 3,953 patients were treated with IVT during the 15-year study period. One hundred thirty-two (3.3%) of the 3,953 patients with AIS had a total of 155 UIAs (141 saccular and 14 fusiform). The mean diameter of UIAs was 4.7 ± 3.8 mm, with 18.7% being ≥7 mm and 9.7% ≥10 mm in diameter. None of the 141 saccular UIAs ruptured after IVT. Three patients (2.3%, 95% confidence interval [CI] 0.6%-5.8%) with large fusiform basilar artery UIAs had a fatal rupture at 27 hours, 43 hours, and 19 days after IVT. All 3 were administered anticoagulation treatments after IVT, and anticoagulation took effect during the UIA rupture. Any ICHs and symptomatic ICHs were detected in 18.9% (95% CI 12.9%-26.2%) and 8.3% (95% CI 4.4%-13.8%) of all patients with AIS, respectively. DISCUSSION: IVT appears to be safe in patients with AIS with saccular UIAs, including larges UIAs (≥10 mm). Anticoagulation after AIS in patients with large fusiform posterior circulation UIAs may increase the risk of aneurysm rupture.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Virta JJ, Strbian D, Putaala J, et al. Risk of Aneurysm Rupture After Thrombolysis in Patients With Acute Ischemic Stroke and Unruptured Intracranial Aneurysms. Neurology. 2021. PMID: 34615686. doi:10.1212/WNL.0000000000012771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。